NCT00617799 2023-10-10Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic MelanomaUniversity of NebraskaCompleted15 enrolled
NCT00492440 2012-10-18Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney CancerCytheris SAPhase 1 Terminated9 enrolled